Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker UONE
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Lemuel Deon Levingston Co-President, Audio Division | UONEK Urban One, Inc. Class D | Sale | 5,646 | $4.15 | $23.4K Sale | Form 4 ↗ |
| Aug 11, 2026 | Lemuel Deon Levingston Co-President, Audio Division | UONEK Urban One, Inc. Class D | Sale | 2,891 | $5.40 | $15.6K Sale | Form 4 ↗ |
| Aug 10, 2026 | Lemuel Deon Levingston Co-President, Audio Division | UONEK Urban One, Inc. Class D | Sale | 88 | $5.40 | $475 Sale | Form 4 ↗ |
| Aug 7, 2026 | Lemuel Deon Levingston Co-President, Audio Division | UONEK Urban One, Inc. Class D | Sale | 1,677 | $5.40 | $9,056 Sale | Form 4 ↗ |
| Aug 6, 2026 | Lemuel Deon Levingston Co-President, Audio Division | UONEK Urban One, Inc. Class D | Sale | 160 | $5.40 | $864 Sale | Form 4 ↗ |
| Dec 26, 2025 | Terry L. Jones Director | UONEK Urban One, Inc. Class D | Sale | 1,400 | $0.85 | $1,190 Sale | Form 4 ↗ |
| Dec 24, 2025 | Terry L. Jones Director | UONEK Urban One, Inc. Class D | Sale | 987 | $0.84 | $829 Sale | Form 4 ↗ |
| Dec 23, 2025 | Terry L. Jones Director | UONEK Urban One, Inc. Class D | Sale | 619 | $0.92 | $569 Sale | Form 4 ↗ |
| Dec 22, 2025 | Terry L. Jones Director | UONEK Urban One, Inc. Class D | Sale | 1,630 | $0.96 | $1,565 Sale | Form 4 ↗ |
| Aug 27, 2025 | Brian W. McNeill Director | UONE/UONEK Urban One, Inc. | Sale | 220,901 | $0.82 | $181.1K Sale | Form 4 ↗ |
| Jan 13, 2025 | David M. Kantor CEO, Radio Division | UONE/UONEK Urban One, Inc. | Sale | 70,350 | $0.98 | $68.9K Sale | Form 4 ↗ |
| Dec 13, 2024 | Karen Wishart CAO/EVP | UONE/UONEK Urban One, Inc. | Sale | 50,000 | $1.01 | $50.5K Sale | Form 4 ↗ |
| Dec 11, 2024 | Kristopher Simpson SVP & General Counsel | UONE/UONEK Urban One, Inc. | Sale | 9,210 | $1.07 | $9,855 Sale | Form 4 ↗ |
| Dec 11, 2024 | Peter Thompson CFO/EVP | UONEK Urban One, Inc. Class D | Sale | 100,000 | $1.07 | $107.0K Sale | Form 4 ↗ |
| Nov 27, 2024 | David M. Kantor CEO, Radio Division | UONEK Urban One, Inc. Class D | Sale | 350,000 | $0.98 | $343.0K Sale | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances